8-K ·Filed Aug 11, 2026

CAH

CARDINAL HEALTH INC
NEUTRAL
Impact 4/10
Horizonimmediate Processed1mo ago SEC0000721371-26-000036
8-K material event: Items 1.01, 1.02
Actionable Insight • Neutral

This is a routine credit facility refinancing with no material change to Cardinal Health's financial position or outlook. Monitor the next quarterly filing for any update on leverage or use of the facility, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
CAH ▼ -0.14% at T+20d
NEUTRAL call ✗ call lost -0.14% · α vs SPY +0.92% · entry $240.26 → $239.92
Next anchor: T+60d in 5w
Latest observation: T+35 -19.02% FF3 residual α
Entry anchored
Aug 11, 06:36 AM ET
via 1-min bar
T+1d
-2.54%
call -2.54% · α -2.79%
$234.16
settled 7w ago
T+5d
-2.20%
call -2.20% · α -1.79%
$234.98
settled 6w ago
T+20d
-0.14%
call -0.14% · α +0.92%
$239.92
settled 23d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility, replacing its existing $2.0 billion five-year facility, $1.0 billion 364-day facility, and $1.0 billion receivables sale program. The new facility matures on August 7, 2031, with an option to extend by up to two years, and carries a maximum consolidated net leverage ratio of 4.00x. This is a routine refinancing that consolidates and extends the company's credit lines at a larger total capacity, with no financial data indicating distress or material change in operations.

Key Financial Metrics

Deal Value
$4.0B
Deal Type
credit_facility

Key Facts

  • Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility on August 7, 2026.
  • The facility matures on August 7, 2031, with an option to extend by up to two years.
  • The new facility replaces the existing $2.0 billion five-year facility, $1.0 billion 364-day facility, and $1.0 billion receivables sale program.
  • The financial covenant requires a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00.
  • No penalties were incurred from the termination of the prior facilities.

Financial Impact

Routine refinancing of $4.0 billion in aggregate credit facilities; no new debt drawn or financial impact disclosed.

debtliquidity

Risk Factors

  • No material risks identified from this routine refinancing.

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000721371-26-000036
Document: cah-20260807.htm0000721371-26-000036
Document: 0000721371-26-000036-index-headers.html0000721371-26-000036
Document: 0000721371-26-000036-index.html0000721371-26-000036
Document: 0000721371-26-000036.txt0000721371-26-000036
8 reports for CAH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CAH — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$228.46 $225.38▼ −1.35%▼ −1.35%$227.72 (−0.32%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$228.46 $225.38▼ −1.35%▼ −1.35%$227.72 (−0.32%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$228.46 $225.38▼ −1.35%▼ −1.35%$227.72 (−0.32%)
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$240.26 $239.92▼ −0.14%▲ +0.92%$227.72 (−5.22%)
Aug 11, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$240.26 $239.92▼ −0.14%▲ +0.92%$227.72 (−5.22%)
Aug 5, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$239.23 $245.49▲ +2.62%▲ +3.22%$227.72 (−4.81%)
Jul 20, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$227.09 $234.98▲ +3.47%▲ +0.91%$227.72 (+0.28%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$215.96 $214.02▼ −0.90%▲ +2.89%$227.72 (+5.45%)
Showing 8 of 8

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access